Primary prevention with the ICD in clinical practice: Not as straightforward as the guidelines suggest?

Netherlands Heart Journal

Volumn 17, Issue 3, 2009, Pages 107-110

  Bracke, F A L E ^a   Dekker, L R C ^a   Van Der Voort, P H ^a   Meijer, A ^a  

^a CATHARINA HOSPITAL   (Netherlands)

Author keywords

Aged; Defibrillators; Implantable; Review; Risk assessment

Indexed keywords

CARDIOVASCULAR RISK; CLINICAL PRACTICE; DEFIBRILLATOR; DEVICE THERAPY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; IMPLANTATION; LONGEVITY; MEDICAL DECISION MAKING; PATIENT SELECTION; PRACTICE GUIDELINE; PRIMARY PREVENTION; REVIEW; SUDDEN DEATH; SURVIVAL RATE;

EID: 70349278518     PISSN: 15685888     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03086228     Document Type: Review

References (41)

1. Epstein AE, Dimarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2008;52:1122-1127
2. van Erven L, van Dessel PFHM, Simmers TA, van Gelder IC, Haurer RNW, Wever EFD. Guidelines ICD implantation 2005 - an update. http://www.cardiologie. nl/2/pagecontent/main-richtlijnen/20060821/icd2005.pdf.
3. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death-executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J 2006;27:2099-2140
4. Tung R, Zimetbaum P, Josephson ME. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol 2008;52:1111-1121
5. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-237 (Pubitemid 40110811)
6. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883 (Pubitemid 34984635)
7. Yap YG, Duong T, Bland JM, et al. Optimising the dichotomy limit for left ventricular ejection fraction in selecting patients for defibrillator therapy after myocardial infarction. Heart 2007;93: 832-836 (Pubitemid 46998983)
8. Curtis JP, Sokol SI, Wang Y, et al. The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure. J Am Coll Cardiol 2003;42:736-742 (Pubitemid 37000196)
9. Otterstad JE, Froeland G, St John Sutton M, Holme I. Accuracy and reproducibility of biplane two-dimensional echocardiographic measurements of left ventricular dimensions and function. Eur Heart J 1997;18:507-513 (Pubitemid 27110484)
10. Hare JL, Brown JK, Marwick TH. Performance of conventional echocardiographic parameters and myocardial measurements in the sequential evaluation of left ventricular function. Am J Cardiol 2008;101:706-711 (Pubitemid 351649349)
11. Buxton AE, Lee KL, Hafley GE, et al. Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study. J Am Coll Cardiol 2007;50:1150-1157
12. Solomon SD, Zelenkofske S, McMurray JJ, et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. New Engl J Med 2005;352:2581-2588 (Pubitemid 41007844)
13. Buxton AE. Sudden death after myocardial infarction - who needs prophylaxis, and when? N Engl J Med 2005;352:2638-2640 (Pubitemid 41007851)
14. Ottervanger JP, Ramdat Misier AR, Dambrink JH, et al. Mortality in patients with left ventricular ejection fraction
15. Pascale P, Taffe P, Regamey C, Kappenberger L, Fromer M. Reduced ejection fraction after myocardial infarction: is it sufficient to justify implantation of a defibrillator? Chest 2005;128:2626-2632 (Pubitemid 41507620)
16. Goldenberg I, Vyas AK, Hall WJ, et al. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 2008;51:288-296
17. Cuculich PS, Sánchez JM, Kerzner R, et al. Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death. PACE 2007;30:207-213
18. Costea A, Rardon DP, Padanilam BJ, Fogel RI, Prystowsky EN. Complications associated with generator replacement in response to device advisories. J Cardiovasc Electrophysiol 2008;19:266-269 (Pubitemid 351294626)
19. Gould PA, Krahn AD. Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories. JAMA 2006;295:1907-1911
20. Kleemann T, Becker T, Doenges K, et al. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation 2007;115 2474-2480 (Pubitemid 46763220)
21. Sola CL, Bostwick JM. Implantable cardioverter-defibrillators, induced anxiety, and quality of life. Mayo Clin Proc 2005;80:232-237 (Pubitemid 40194537)
22. Thomas SA, Friedmann E, Kao CW, et al. Quality of life and psychological status of patients with implantable cardioverter defibrillators. Am J Crit Care 2006;15:389-398 (Pubitemid 44859179)
23. Sweeney MO, Wathen MS, Volosin K, et al. Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial. Circulation 2005;111:2898-2905 (Pubitemid 40814182)
24. Daubert JP, Zareba W, Cannom DS, et al. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 2008;51:1357-1365
25. Maron BJ, Spirito P, Shen WK, et al. Implantable cardioverter- defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA 2007;298:405-412 (Pubitemid 47124061)
26. Korte T, Köditz H, Niehaus M, Paul T, Tebbenjohanns J. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator. PACE 2004;27:924-932
27. Mark DB, Nelson CL, Anstrom KJ, et al. Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Circulation 2006;114:135-142
28. Zwanziger J, Hall WJ, Dick AW, et al. The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol 2006;47:2310-2318 (Pubitemid 43795065)
29. Healey JS, Hallstrom AP, Kuck KH, et al. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias. Eur Heart J 2007;28:1746-1749
30. Grimm W. Outcomes of elderly heart failure recipients of ICD and CRT. Int J Cardiol 2008;125:154-160
31. Ellenbogen KA, Levine JH, Berger RD, et al. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation 2006;113:776-782
32. Borleffs CJ, Wilde AA, Cramer MJ, Wever E, Mosterd A. Clinical implementation of guidelines for cardioverter defibrillator implantation: lost in translation? Neth Heart J 2007;15:129-132 (Pubitemid 47253679)
33. Siu LL. Clinical trials in the elderly-a concept comes of age. New Engl J Med 2007;356:1575-1576
34. Bokhari F, Newman D, Greene M, Korley V, Mangat I, Dorian P. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS). Circulation 2004;110:112-116 (Pubitemid 38924577)
35. de Vreede-Swagemakers JJ, Gorgels AP, Dubois-Arbouw WI, et al. Out-of-hospital cardiac arrest in the 1990's: a population-based study in the Maastricht area on incidence, characteristics and survival. J Am Coll Cardiol 1997;30:1500-1505
36. Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med 2001;345:1473-1482
37. Josephson M, Rosen M, Tomaselli G. The year in arrhythmias - 2007: Part I. Heart Rhythm 2008;5:742-748
38. Myles RC, Jackson CE, Tsorlalis I, Petrie MC, McMurray JJ, Cobbe SM. Is microvolt T-wave alternans the answer to risk stratification in heart failure? Circulation 2007;116:2984-2991 (Pubitemid 350291206)
39. Buxton AE, Hafley GE, Lehmann MH, et al. Prediction of sustained ventricular tachycardia inducible by programmed stimulation in patients with coronary artery disease. Utility of clinical variables. Circulation 1999;99:1843-1850
40. Dekker LR, Bezzina CR, Henriques JP, et al. Familial sudden death is an important risk factor for primary ventricular fibrillation: a case-control study in acute myocardial infarction patients. Circulation 2006;114:1140-1145
41. Arking DE, Chugh SS, Chakravarti A, Spooner PM. Genomics in sudden cardiac death. Circ Res 2004;94:712-723